COCRYSTAL PHARMA, INC. Share-based Payment Arrangement, Expense
COCRYSTAL PHARMA, INC. (COCP) reported Share-based Payment Arrangement, Expense of $176.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-13
- COCRYSTAL PHARMA, INC. share-based payment arrangement, expense for the quarter ending 2026-06-30 was $92.00K, a 9.52% increase year-over-year.
- COCRYSTAL PHARMA, INC. share-based payment arrangement, expense for the quarter ending 2026-03-31 was $84.00K, a 2.44% increase year-over-year.
- COCRYSTAL PHARMA, INC. share-based payment arrangement, expense for the quarter ending 2025-12-31 was $56.00K, a 34.88% decline year-over-year.
- COCRYSTAL PHARMA, INC. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $48.00K, a 80.95% decline year-over-year.
- COCRYSTAL PHARMA, INC. share-based payment arrangement, expense for fiscal 2025 was $270.00K, a 58.01% decline from fiscal 2024.
- COCRYSTAL PHARMA, INC. share-based payment arrangement, expense for fiscal 2024 was $643.00K, a 19.73% decline from fiscal 2023.
- COCRYSTAL PHARMA, INC. share-based payment arrangement, expense for fiscal 2023 was $801.00K, a 6.32% decline from fiscal 2022.
- COCRYSTAL PHARMA, INC. share-based payment arrangement, expense for fiscal 2022 was $855.00K, a 18.09% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 6 month as first filed | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 9 month as first filed | Share-based Payment Arrangement, Expense 12 month | Share-based Payment Arrangement, Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $92.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $176.00K 10-Q · filed 2026-08-13 | $232.00K derived: sum of 3 quarters · filed 2026-08-13 | $280.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $84.00K 10-Q · filed 2026-05-15 | $140.00K derived: sum of 2 quarters · filed 2026-05-15 | $188.00K derived: sum of 3 quarters · filed 2026-05-15 | $272.00K derived: sum of 4 quarters · filed 2026-05-15 | ||||
| 2025-12-31 | $56.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $104.00K derived: sum of 2 quarters · filed 2026-03-31 | $188.00K derived: sum of 3 quarters · filed 2026-03-31 | $270.00K 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | $48.00K 10-Q · filed 2025-11-14 | $132.00K derived: sum of 2 quarters · filed 2025-11-14 | $214.00K 10-Q · filed 2025-11-14 | $300.00K derived: sum of 4 quarters · filed 2026-05-15 | ||||
| 2025-06-30 | $84.00K 10-Q · filed 2025-08-14 | $166.00K 10-Q · filed 2026-08-13 | $148.00K 10-Q · filed 2025-08-14 | $252.00K derived: sum of 3 quarters · filed 2026-05-15 | $504.00K derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2025-03-31 | $82.00K 10-Q · filed 2026-05-15 | $168.00K derived: sum of 2 quarters · filed 2026-05-15 | $420.00K derived: sum of 3 quarters · filed 2026-05-15 | $586.00K derived: sum of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | $86.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $338.00K derived: sum of 2 quarters · filed 2026-03-31 | $504.00K derived: sum of 3 quarters · filed 2026-03-31 | $643.00K 10-K · filed 2026-03-31 | ||||
| 2024-09-30 | $252.00K 10-Q · filed 2025-11-14 | $418.00K derived: sum of 2 quarters · filed 2025-11-14 | $557.00K 10-Q · filed 2025-11-14 | $173.00K 10-Q · filed 2024-11-13 | $733.00K derived: sum of 4 quarters · filed 2025-11-14 | |||
| 2024-06-30 | $166.00K 10-Q · filed 2025-08-14 | $148.00K 10-Q · filed 2024-08-14 | $305.00K 10-Q · filed 2025-08-14 | $481.00K derived: sum of 3 quarters · filed 2025-08-14 | $1.04M derived: sum of 4 quarters · filed 2025-08-14 | |||
| 2024-03-31 | $157.00K 10-Q · filed 2025-05-15 | $315.00K derived: sum of 2 quarters · filed 2025-05-15 | $872.00K derived: sum of 3 quarters · filed 2025-05-15 | $1.05M derived: sum of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | $158.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $715.00K derived: sum of 2 quarters · filed 2025-03-31 | $894.00K derived: sum of 3 quarters · filed 2025-03-31 | $801.00K 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | $557.00K 10-Q · filed 2024-11-13 | $173.00K 10-Q · filed 2023-11-13 | $736.00K derived: sum of 2 quarters · filed 2024-11-13 | $643.00K 10-Q · filed 2024-11-13 | $216.00K 10-Q · filed 2023-11-13 | $1.19M derived: sum of 4 quarters · filed 2024-11-13 | ||
| 2023-06-30 | $179.00K 10-Q · filed 2024-08-14 | $241.00K 10-Q · filed 2024-08-14 | $629.00K derived: sum of 3 quarters · filed 2024-08-14 | $1.27M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | $291.00K 10-Q · filed 2024-05-13 | $450.00K derived: sum of 2 quarters · filed 2024-05-13 | $1.09M derived: sum of 3 quarters · filed 2024-05-13 | $1.56M derived: sum of 4 quarters · filed 2024-05-13 | ||||
| 2022-12-31 | $159.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $802.00K derived: sum of 2 quarters · filed 2024-03-28 | $1.27M derived: sum of 3 quarters · filed 2024-03-28 | $855.00K 10-K · filed 2024-03-28 | ||||
| 2022-09-30 | $643.00K 10-Q · filed 2023-11-13 | $216.00K 10-Q · filed 2022-11-14 | $1.11M derived: sum of 2 quarters · filed 2023-11-13 | $696.00K 10-Q · filed 2023-11-13 | $1.57M derived: sum of 4 quarters · filed 2023-11-13 | |||
| 2022-06-30 | $470.00K 10-Q · filed 2023-08-14 | $241.00K 10-Q · filed 2022-08-15 | $480.00K 10-Q · filed 2023-08-14 | $931.00K derived: sum of 3 quarters · filed 2023-08-14 | $1.14M derived: sum of 4 quarters · filed 2023-08-14 | |||
| 2022-03-31 | $239.00K 10-Q · filed 2023-05-15 | $461.00K derived: sum of 2 quarters · filed 2023-05-15 | $666.00K derived: sum of 3 quarters · filed 2023-05-15 | $744.00K derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $222.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $427.00K derived: sum of 2 quarters · filed 2023-03-29 | $505.00K derived: sum of 3 quarters · filed 2023-03-29 | $724.00K 10-K · filed 2023-03-29 | $724.00 10-K · filed 2022-03-23 | |||
| 2021-09-30 | $205.00K 10-Q · filed 2022-11-14 | $283.00K derived: sum of 2 quarters · filed 2022-11-14 | $502.00K 10-Q · filed 2022-11-14 | $237.00K 10-Q · filed 2021-11-15 | $701.00K derived: sum of 4 quarters · filed 2022-11-14 | |||
| 2021-06-30 | $78.00K 10-Q · filed 2022-08-15 | $297.00K 10-Q · filed 2022-08-15 | $496.00K derived: sum of 3 quarters · filed 2022-08-15 | $998.00K derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | $219.00K 10-Q · filed 2022-05-11 | $418.00K derived: sum of 2 quarters · filed 2022-05-11 | $920.00K derived: sum of 3 quarters · filed 2022-05-11 | $1.04M derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2020-12-31 | $199.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $701.00K derived: sum of 2 quarters · filed 2022-03-23 | $820.00K derived: sum of 3 quarters · filed 2022-03-23 | $662.00K 10-K · filed 2022-03-23 | ||||
| 2020-09-30 | $502.00K 10-Q · filed 2021-11-15 | $237.00K 10-Q · filed 2020-11-13 | $621.00K derived: sum of 2 quarters · filed 2021-11-15 | $463.00K 10-Q · filed 2021-11-15 | $826.00K derived: sum of 4 quarters · filed 2021-11-15 | |||
| 2020-06-30 | $119.00K 10-Q · filed 2021-08-16 | $226.00K 10-Q · filed 2021-08-16 | $324.00K derived: sum of 3 quarters · filed 2021-08-16 | $432.00K derived: sum of 4 quarters · filed 2021-08-16 | ||||
| 2020-03-31 | $107.00K 10-Q · filed 2021-05-17 | $205.00K derived: sum of 2 quarters · filed 2021-05-17 | $313.00K derived: sum of 3 quarters · filed 2021-05-17 | $426.00K derived: sum of 4 quarters · filed 2021-05-17 | ||||
| 2019-12-31 | $98.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | $206.00K derived: sum of 2 quarters · filed 2021-03-17 | $319.00K derived: sum of 3 quarters · filed 2021-03-17 | $351.00K 10-K · filed 2021-03-17 | ||||
| 2019-09-30 | $108.00K 10-Q · filed 2020-11-13 | $221.00K derived: sum of 2 quarters · filed 2020-11-13 | $253.00K 10-Q · filed 2020-11-13 | |||||
| 2019-06-30 | $113.00K 10-Q · filed 2020-08-06 | $146.00K 10-Q · filed 2020-08-06 | ||||||
| 2019-03-31 | $33.00K 10-Q · filed 2020-05-13 | |||||||
| 2018-09-30 | $120.00K 10-Q · filed 2018-11-09 | $227.00K derived: sum of 2 quarters · filed 2018-11-09 | $332.00K 10-Q · filed 2018-11-09 | |||||
| 2018-06-30 | $107.00K 10-Q · filed 2018-08-09 | $212.00K 10-Q · filed 2018-08-09 | ||||||
| 2018-03-31 | $105.00K 10-Q · filed 2018-05-10 | |||||||
| 2017-09-30 | $142.00K 10-Q · filed 2018-11-09 | $196.00K derived: sum of 2 quarters · filed 2018-11-09 | $409.00K 10-Q · filed 2018-11-09 | |||||
| 2017-06-30 | $54.00K 10-Q · filed 2018-08-09 | $268.00K 10-Q · filed 2018-08-09 | ||||||
| 2017-03-31 | $212.00K 10-Q · filed 2018-05-10 | |||||||
| 2016-06-30 | $719.00K 10-Q · filed 2017-08-08 | $1.44M 10-Q · filed 2017-08-08 | ||||||
| 2016-03-31 | $719.00K 10-Q · filed 2017-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |